nivolumab
bms
[]
4/ safety: acute grade 3 toxicity related to ici at 3 &amp; 6 months was 3%. no grade 4+ toxicity at 3 months, nor grade 3+ toxicity at 6 months. encouraging for patients &amp; clinicians. #aacr23
Radiation Oncology Resident @MoffittRadOnc // @ARRO_org Communications Subcommittee // Husband + Girl Dad